New shot aims to prevent dangerous clots in High-Risk patients
Disease control
Recruiting now
This early-stage study tests a single injection of a new drug called CITY-FXI in healthy adults and those with Factor V Leiden or prothrombin G20210A mutation, which increase blood clot risk. The goal is to see if the drug is safe and how it works in the body. About 128 participa…
Phase: PHASE1 • Sponsor: City Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:52 UTC